Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 4

2(25.0%)

8Total

N/A(6)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06623617Not ApplicableRecruiting

The Impact of Breathing Training on PPSUI: A Randomized Controlled Trial

Role: lead

NCT06819423Not ApplicableRecruiting

The Impact of AI-Based Fundus Imaging on Blood Glucose Control and Fundus Examination Completion Rates in Outpatient Diabetic Patients

Role: lead

NCT06300918Not ApplicableRecruiting

A Clinical Trial to Evaluate the Time Point of Anti-VEGF Pretreatment of PDR Based on Intraoperative FFA

Role: lead

NCT06269419Recruiting

Study of Natural Course Progression of Diabetic Retinopathy

Role: lead

NCT04654754Not ApplicableCompleted

Aerosol Particle Concentrations Among Different Oxygen Devices for Spontaneous Breathing Patients With Tracheostomy

Role: lead

NCT05626309Not ApplicableUnknown

Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer

Role: lead

NCT05229809Phase 4Unknown

Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer

Role: lead

NCT03986528Phase 4Unknown

Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)

Role: lead

NCT03458364Not ApplicableCompleted

Comparison of HFNC With NIV in Weaning COPD

Role: lead

All 9 trials loaded